Data from FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy
Authors:
- Donna PrzepiorkaDPDonna Przepiorka
- Robert Q. LeRLRobert Q. Le
- Alexei IonanAIAlexei Ionan
- Ruo-Jing LiRLRuo-Jing Li
- Ying-Hong WangYWYing-Hong Wang
- Ramadevi GudiRGRamadevi Gudi
- Soumya MitraSMSoumya Mitra
- Jonathon VallejoJVJonathon Vallejo
- Olanrewaju O. OkusanyaOOOlanrewaju O. Okusanya
- Lian MaLMLian Ma
- Yuching YangYYYuching Yang
- Paresma PatelPPParesma Patel
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)